SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUniphar Regulatory News (UPR)

Share Price Information for Uniphar (UPR)

Share Price is delayed by 15 minutes
Get Live Data
424.00    6.00 (1.44%)
Bid:
420.00
Ask:
428.00
Spread: 8.00 (1.905%)
Market Cap: £1.10b
UPR Live PriceLast checked at - London Stock Exchange

Intraday Uniphar Share Chart

AGM Results

11 May 2023 15:32

RNS Number : 1538Z
Uniphar PLC
11 May 2023
 

AGM Results

 

Dublin, London | 11 May 2023

 

 

Uniphar plc (the Company) is pleased to announce that at its Annual General Meeting held at 11.00 a.m. today, 11 May 2023, each of the resolutions set out in the Notice of Annual General Meeting circulated to shareholders and made available on the Company's website, www.uniphar.ie, were duly passed without amendment.

 

Details of votes cast are set out below:

 

 

 

RESOLUTION

For

For %

Against

Against

%

Withheld

1

Financial Statements and Reports

152,222,114

100.00%

-

0.00%

122,760

2

Final Dividend of €3.1m

152,344,874

100.00%

-

0.00%

-

3(a)

Re-elect Ger Rabbette

143,343,970

94.10%

8,983,856

5.90%

-

3(b)

Re-elect Tim Dolphin

151,670,590

99.58%

646,008

0.42%

28,276

3(c)

Re-elect Paul Hogan

126,308,788

91.68%

11,470,073

8.32%

14,566,013

3(d)

Re-elect Sue Webb

145,057,596

95.22%

7,287,278

4.78%

-

3(e)

Re-elect Jeff Berkowitz

135,359,924

88.85%

16,984,950

11.15%

-

3(f)

Re-elect Jim Gaul

143,367,303

94.11%

8,977,571

5.89%

-

3(g)

Re-elect Liz Hoctor

145,145,135

95.27%

7,199,739

4.73%

-

3(h)

Re-elect Maurice Pratt

146,755,320

97.96%

3,053,597

2.04%

2,535,957

4

Remuneration of Auditors*

101,192,290

67.55%

48,616,627

32.45%

2,535,957

5

Allot relevant securities

139,001,133

91.24%

13,343,741

8.76%

-

6

Disapplication of pre-emption rights in specified circumstances

151,875,721

99.78%

334,459

0.22%

128,941

7

Disapplication of pre-emption rights in additional circumstances

135,251,268

88.84%

16,992,560

11.16%

101,046

8

Authorise market purchases of the Company's Ordinary Shares

151,780,712

100.00%

-

0.00%

564,162

9

Re-issuance of Treasury Shares

152,344,874

100.00%

-

0.00%

-

10

Amendment of the Company's Articles of Association to provide for electronic communications

152,311,226

100.00%

-

0.00%

33,648

 

 

\* The Board notes that Resolution 4 passed with a majority of less than 80% (receiving votes in favour of 67.55%). In accordance with provision 4 of the UK Corporate Governance Code (the "Code"), the Board confirms that it will engage with shareholders to understand and discuss the reasons behind the votes received against this resolution. An update on the views received from shareholders and actions taken will be provided within six months of the Annual General Meeting, in accordance with the Code.

 

 

--- ENDS ---

 

 

For further details contact:

 

Uniphar Group

 

Tel: +353 (0) 1 428 7777

Allan Smylie, Head of Strategy and IR

Davy (Joint Corporate Broker, Nominated Advisor and

Euronext Growth Listing Sponsor)

 

Tel: +353 (0) 1 679 6363

Daragh O'Reilly

Niall Gilchrist

Ivan Murphy

RBC Capital Markets (Joint Corporate Broker)

 

Tel: +44 (0) 20 7653 4000

Jonathan Hardy

Jamil Miah

Stifel Nicolaus Europe Limited (Joint Corporate Broker)

 

Tel: +44 (0) 20 7710 7600

Matt Blawat

Ben Maddison

Francis North

Q4 PR

 

Tel: +353 (0) 1 475 1444

Iarla Mongey, Public Relations Advisor to Uniphar Group

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKDBNQBKDDPD
Date   Source Headline
4th Oct 20227:00 amRNSAcquisition of healthcare agency Inspired Health
19th Sep 20227:00 amRNSAcquisition of McCauley Pharmacy Group
14th Sep 20229:08 amRNSDirector/PDMR Shareholding
30th Aug 20227:00 amRNS2022 Interim Results
26th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
11th May 20224:16 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
7th Apr 20227:00 amRNSNotice of AGM & Annual Report
3rd Mar 20227:31 amRNSDirector/PDMR Shareholding
3rd Mar 20227:29 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20227:00 amRNS2021 Preliminary Results
21st Feb 20228:00 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSFull Year Trading Update & Notice of Results
23rd Dec 20217:00 amRNSAcquisitions of E4H, Devonshire and Navi Group
17th Dec 20217:00 amRNSDirectorate Change
3rd Dec 20217:00 amRNSHolding(s) in Company
23rd Nov 20213:22 pmRNSHolding(s) in Company
15th Nov 20214:02 pmRNSHolding(s) in Company
14th Oct 202111:31 amRNSHolding(s) in Company
7th Sep 20217:00 amRNSHolding(s) in Company
3rd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNS2021 Interim Results
19th Aug 20215:24 pmRNSHolding(s) in Company
2nd Aug 20217:00 amRNSAcquisition of BESTMSLs Group
27th Jul 20217:00 amRNSHalf Year Trading Update and Notice of Results
20th Jul 20217:00 amRNSAcquisition of CoRRect Medical GmbH
12th May 20213:12 pmRNSResult of AGM
12th May 20217:00 amRNSAGM Statement
10th May 20218:29 amRNSHolding(s) in Company
7th May 20218:00 amRNSDirector/PDMR Shareholding
27th Apr 202112:44 pmRNSHolding(s) in Company
16th Apr 20214:59 pmRNSHolding(s) in Company
8th Apr 20217:00 amRNSNotice of AGM & Annual Report
4th Mar 20217:30 amRNSDirector/PDMR Shareholding
4th Mar 20217:30 amRNSExecutive Restricted Share Plan Dealing
2nd Mar 20217:00 amRNS2020 Preliminary Results
25th Feb 20217:00 amRNSConsent to Migration
15th Feb 20213:00 pmRNSResult of EGM
28th Jan 20213:57 pmRNSHolding(s) in Company
27th Jan 20217:00 amRNSDirectorate Changes
27th Jan 20217:00 amRNSFull Year Trading Update & Notice of Results
20th Jan 20219:00 amRNSCurrency Change on LSE
20th Jan 20217:00 amRNSNotice of EGM
7th Jan 20214:27 pmRNSHolding(s) in Company
22nd Dec 20203:00 pmRNSDirector/PDMR Shareholding
9th Dec 20207:00 amRNSAppointment of Joint Corporate Broker
24th Nov 20207:00 amRNSAcquisition of RRD International
23rd Nov 20207:00 amRNSAcquisition
2nd Nov 20203:30 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSAcquisition of Diligent Health Solutions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.